Evaluation of an Advanced Lower Extremity Neuroprostheses (LE-IST)

June 12, 2025 updated by: Ronald J. Triolo, Case Western Reserve University

Evaluation of Advanced Lower Extremity Neuroprostheses

The purpose of this study is to evaluate a surgically implanted functional electrical stimulation (FES) system to facilitate exercise, standing, stepping and/or balance in people with various degrees of paralysis.

Study Overview

Detailed Description

Protocol Outline: Patents undergo surgery in which electrodes are implanted into muscles of the trunk and legs. Electrode leads are connected to an stimulator/telemeter. Following implantation, patients undergo training in standing, transfers and other advanced mobility skills using the functional electrical stimulation system. A prescribed course of exercise, functional training and rehabilitation with the implanted stimulation system, followed by laboratory assessments of strength, balance and functional abilities with and without the system, as well as the technical performance of the implanted components. Home-based training follows prior to discharge for home use of the system.

Patients are followed at 6 and 12 months after discharge and then annually thereafter.

Study Type

Interventional

Enrollment (Estimated)

10

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Ohio
      • Cleveland, Ohio, United States, 44109
        • Recruiting
        • MetroHealth System
        • Contact:
        • Contact:
        • Principal Investigator:
          • Ronald J Triolo, Ph.D.
      • Cleveland, Ohio, United States, 44106
        • Recruiting
        • Louis Stokes Cleveland VA Medical Center
        • Contact:
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

21 years to 75 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Phase I Inclusion Criteria

  1. Skeletal maturity and ability to sign informed consent (>18 years)
  2. Non-ventilator dependent paralysis resulting from injuries such as: mid cervical/thoracic (C4 or below) spinal cord injuries, poststroke hemiparesis, TBI, or MS, affecting the trunk and/or lower limbs
  3. Innervated and excitable lower extremity and trunk musculature
  4. Adequate social support and stability
  5. Willingness to comply with follow-up procedures

Phase I Exclusion Criteria

  1. Non-English speaking
  2. Females who are pregnant
  3. Current pressure injuries that would be exacerbated by study activities
  4. Severe contractures or uncontrolled spasticity of any major joint of the upper or lower extremities that results in a fixed deformity that would interfere with study activities
  5. History of spontaneous fractures or other evidence of excessively low bone density
  6. History of vestibular dysfunction, balance problems, or spontaneous falls
  7. Acute and or/untreated orthopedic problems that would prevent a participant from weight bearing or exercising such as a dislocation or fracture.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Device Feasibility
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Implant
Volunteers are evaluated for appropriateness for inclusion in the study on an intent-to-treat basis. Qualifying candidates all receive the implanted neuroprosthesis and participate in post-operative training and follow-up procedures.
Pre-surgical exercise with surface electrical stimulation, surgery including electrode and IST- implanted pulse generator insertion, exercise and physical therapy with the implanted system, functional training and laboratory assessment of clinical and technical performance.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Device reliability and technical performance measuring changes in standing duration from baseline at discharge to 12 months after discharge
Time Frame: Change from immediately after intervention and 1 year after intervention
Repeated measures of standing duration in minutes
Change from immediately after intervention and 1 year after intervention
Device reliability and technical performance measuring changes in standing loads from baseline at discharge to 12 months after discharge
Time Frame: Change from immediately after intervention and 1 year after intervention
Repeated measures of arm/leg loading measured in Kg
Change from immediately after intervention and 1 year after intervention
Device reliability and technical performance measuring changes in walking distance from baseline at discharge to 12 months after discharge
Time Frame: Change from immediately after intervention and 1 year after intervention
Repeated measures of walking distance in meters
Change from immediately after intervention and 1 year after intervention
Device reliability and technical performance measuring changes in walking duration from baseline at discharge to 12 months after discharge
Time Frame: Change from immediately after intervention and 1 year after intervention
Repeated measures of walking time in minutes
Change from immediately after intervention and 1 year after intervention

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Device operability measuring changes in functional activities of daily living from baseline at discharge and 12 months after discharge
Time Frame: Change from immediately after intervention and 1 year after intervention
Repeated measures of standing reach in cm, and transfer height in cm
Change from immediately after intervention and 1 year after intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Ronald J Triolo, Ph.D., Case Western Reserve University
  • Principal Investigator: Musa L Audu, Ph.D., Louis Stokes Cleveland VA Medical Center

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 1, 2018

Primary Completion (Estimated)

December 31, 2027

Study Completion (Estimated)

December 31, 2027

Study Registration Dates

First Submitted

January 24, 2008

First Submitted That Met QC Criteria

February 15, 2008

First Posted (Estimated)

February 26, 2008

Study Record Updates

Last Update Posted (Actual)

June 15, 2025

Last Update Submitted That Met QC Criteria

June 12, 2025

Last Verified

June 1, 2025

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stroke

Clinical Trials on IST (Implanted Stimulator-Telemeter)

Subscribe